MintLean R·
Oxford begins first human trial of Bundibugyo Ebola vaccine
The Serum Institute of India has supplied 4,000 investigational doses for the Phase I study.
Read at Mint →
Business · 2 sources covering this
Oxford begins first human trial of Bundibugyo Ebola vaccine
The Serum Institute of India has supplied 4,000 investigational doses for the Phase I study.
Coverage spectrum
0 L · 0 C · 2 R
How 2 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/698019e5d43816e3182b94091ebe20ccd2719663" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Oxford begins first human trial of Bundibugyo Ebola vaccine"></iframe>
